Early-demographic dividend vs Kazakhstan: Immunization, HepB3
Early-demographic dividend
86.7%
in 2024
Kazakhstan
98.0%
in 2024
Early-demographic dividend rank
20th
Kazakhstan rank
19th
Immunization, HepB3 over time
- Early-demographic dividend
- Kazakhstan
How they compare
Kazakhstan currently reports 98.0% against 86.7% in Early-demographic dividend, a difference of 11.3%.
That makes Kazakhstan's figure about 1.1 times Early-demographic dividend's.
The two have swapped places 2 times across 27 shared years of data; in 1998 it was Kazakhstan ahead.
Early-demographic dividend ranks 20th and Kazakhstan ranks 19th of 47 groups.
Kazakhstan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Early-demographic dividend | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.9% | 69.5% | 54.6% | Kazakhstan |
| 2000s | 39.7% | 97.2% | 57.5% | Kazakhstan |
| 2010s | 79.5% | 96.2% | 16.7% | Kazakhstan |
| 2020s | 84.9% | 95.4% | 10.5% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Early-demographic dividend or Kazakhstan?
- Kazakhstan, at 98.0% against 86.7% in Early-demographic dividend as of 2024.
- What is the difference in immunization, hepb3 between Early-demographic dividend and Kazakhstan?
- 11.3%, with Kazakhstan ahead.
- How many years of comparable data are there for Early-demographic dividend and Kazakhstan?
- 27 years are reported by both, from 1998 to 2024.
- How do Early-demographic dividend and Kazakhstan rank globally for immunization, hepb3?
- Early-demographic dividend ranks 20th and Kazakhstan ranks 19th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.